Suppr超能文献

基于系统评价和荟萃分析的第二原发性肺癌手术结果和预后因素评估。

Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis.

机构信息

Department of Thoracic Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, China.

Department of Thoracic Surgery, Taihe Hospital (Hubei University of Medicine), Shiyan, China.

出版信息

BMC Surg. 2023 Apr 21;23(1):95. doi: 10.1186/s12893-023-02003-9.

Abstract

BACKGROUND

Although surgery has been widely applied for SPLC therapy, there is still no uniform treatment approach. Whether SPLC and primary lung cancer have similar prognostic characteristics remains controversial. Herein, based on a systematic review and meta-analysis, we aimed to enucleate the influences of diverse surgical strategies and underlying prognostic factors on the prognosis of patients with both the first primary lung cancer and SPLC underwent surgical resection.

METHODS

A comprehensive and systematic literature search was implemented in three databases (MEDLINE, EMBASE, and Cochrane), and eligible studies were screened following inclusion and exclusion criteria. Meanwhile, we extracted the hazard ratios (HR) together with 95% confidence intervals (CI) for each prognostic factor, either directly or indirectly, from the enrolled literature.

RESULTS

Eleven studies (published between 2000 and 2022) were included in this study, including 1,131 SPLC patients. The overall survival (OS) exhibited no difference between patients with lobectomy and sublobar resection after SPLC (HR: 0.87, 95%CI: 0.62-1.21, P = 0.41). The patients after completion pneumonectomy had a poor prognosis (HR: 1.85, 95% CI: 1.34-2.55, P < 0.01). Poor prognostic factors after SPLC surgery included synchronous SPLC (HR: 3.38, 95%CI: 1.53-7.46, P < 0.01), tumor diameter > 2 cm (HR: 2.44, 95%CI: 1.73-3.44, P < 0.01), solid predominant in CT morphology (HR: 3.08, 95% CI: 1.14-8.33, P = 0.03), lymph node metastasis (HR: 2.79, 95%CI: 1.40-5.56), and smoking (HR: 2.37, 95%CI: 1.08-26.82, P < 0.01). Tumor disease-free interval (DFI), tumor histological type, and gender had no impact on the prognosis of patients received SPLC surgery.

CONCLUSIONS

Patients with SPLC, especially those with poor cardiopulmonary function reserve, should be prioritized for sublobar resection for treatment. These patients should also try to avoid completion pneumonectomy. Patients with synchronous SPLC, tumor diameter > 2 cm, solid predominant in CT morphology, lymph node metastasis, and smoking had a poor prognosis. Meanwhile, SPLC has similar prognostic characteristics with single primary lung cancer. However, the study has some limitations and more evidence is warranted to verify the findings.

摘要

背景

尽管手术已广泛应用于 SPLC 治疗,但仍没有统一的治疗方法。SPLC 和原发性肺癌是否具有相似的预后特征仍存在争议。在此,我们基于系统评价和荟萃分析,旨在明确不同的手术策略和潜在的预后因素对接受手术切除的同时患有原发性肺癌和 SPLC 的患者预后的影响。

方法

我们在三个数据库(MEDLINE、EMBASE 和 Cochrane)中进行了全面和系统的文献检索,并根据纳入和排除标准筛选了符合条件的研究。同时,我们直接或间接地从纳入的文献中提取了每个预后因素的风险比(HR)及其 95%置信区间(CI)。

结果

这项研究纳入了 11 项研究(发表于 2000 年至 2022 年之间),共包括 1131 例 SPLC 患者。SPLC 后行肺叶切除术和亚肺叶切除术的总生存(OS)无差异(HR:0.87,95%CI:0.62-1.21,P=0.41)。完成全肺切除术的患者预后较差(HR:1.85,95%CI:1.34-2.55,P<0.01)。SPLC 术后的不良预后因素包括同步 SPLC(HR:3.38,95%CI:1.53-7.46,P<0.01)、肿瘤直径>2cm(HR:2.44,95%CI:1.73-3.44,P<0.01)、CT 形态以实体为主(HR:3.08,95%CI:1.14-8.33,P=0.03)、淋巴结转移(HR:2.79,95%CI:1.40-5.56)和吸烟史(HR:2.37,95%CI:1.08-26.82,P<0.01)。肿瘤无病间隔(DFI)、肿瘤组织学类型和性别对 SPLC 手术患者的预后无影响。

结论

对于心肺储备功能差的 SPLC 患者,应优先考虑行亚肺叶切除术治疗。这些患者还应尽量避免全肺切除术。同时患有 SPLC、肿瘤直径>2cm、CT 形态以实体为主、淋巴结转移和吸烟史的患者预后较差。同时,SPLC 与原发性肺癌具有相似的预后特征。然而,本研究存在一些局限性,需要更多证据来验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e48/10120155/fd032861749e/12893_2023_2003_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验